Related Experiment Video
Updated: Aug 9, 2026

12:06
Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines
Published on: November 25, 2017
[Beta mannosidosis: a new case]
E Gourrier1, M P Thomas, A Munnich
1Service de néonatologie et réanimation, hôpital René-Dubos, Pontoise, France.
Summary
Beta mannosidase deficiency is a rare genetic disorder. This case highlights swallowing and esophageal motility issues in a patient with beta mannosidosis, leading to recurrent infections.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Beta mannosidase deficiency is an extremely rare lysosomal storage disorder.
- Only 11 cases have been previously reported in medical literature.
- This report details a new case, expanding the known clinical spectrum.
Related Concept Videos
Pedigree Analysis
Overview
Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...

